# Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)

> **NCT05016050** · NA · COMPLETED · sponsor: **Happify Inc.** · enrollment: 367 (actual)

## Conditions studied

- Major Depressive Disorder
- Generalized Anxiety Disorder

## Interventions

- **DEVICE:** HPDT-DA-013

## Key facts

- **NCT ID:** NCT05016050
- **Lead sponsor:** Happify Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-04-14
- **Target enrollment:** 367 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016050, "Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05016050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*